Inflammatory Pathways in Diabetes

Autorenportrait

Dr. Pugia is the Principal Key Expert at Siemens Healthcare Diagnostics in the Strategic Innovation Group in Strategy and Business Development. Over the last 25 years, he has held various Research & Development positions and been involved in over 20 new products in the MULTISTIX, CLINITEK, CLINITEST and DCA brands for urinalysis and professional diabetes as well as other business units. He has a Ph.D. in Chemistry from Texas Tech University (1986), a B.S. in Chemistry from Clarkson University (1982) and was Visiting Scholar at the University of Notre Dame (2004-2008). His research areas are proteomic biomarker discovery and treatment in inflammatory immune diseases in the field of endocrinology and onocology. He has 256 patents world wide, 48 full-length manuscripts and 6 book chapters in a wide variety of chemistry disciplines. In 2009, he was a Siemens Inventor of the Year, he was the first Al Free Memorial Lecturer in 2001 and in 2002 was awarded the Samual Natelson Award by the American Association for Clinical Chemistry. He has also been awarded nine corporate Science and Technology Awards while in Bayer and Miles Diagnostics.

Weitere Details